Answers are grounded in this paper and cite their sources.
Prevalence of MHE is high in patients with cirrhosis of liver. Rifaximin, LOLA, and probiotics are better than giving placebo in patients with MHE.
No takes yet. Share an insight, caveat, or question.
Sharma et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: